Author

Lauren Michael

Institution: Moffitt Cancer Center

Observed institution: Moffitt Cancer Center

OpenAlex ID: A5041544177

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

2022 · Sungjune Kim, Evan Wuthrick, et al. · The Lancet · 146

Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy

2024 · Aasha I. Hoogland, Andrew S. Brohl, et al. · Cancer Medicine · 3

Works count: 2

Citation count: 149

H-index: 2

I10-index: 1